-+ 0.00%
-+ 0.00%
-+ 0.00%

Canbridge Pharmaceuticals files list of directors, board committee roles and disclosure-responsible management

PUBT·08/05/2026 23:04:47
Listen to the news
Canbridge Pharmaceuticals files list of directors, board committee roles and disclosure-responsible management
  • Canbridge Pharmaceuticals listed its board and committee line-up as of Aug. 5, 2026, led by executive director James Qun Xue as chairman, CEO.
  • Non-executive directors: Wei Zhao, Tingwei Wang; independent non-executive directors include Richard Arthur Moscicki, James Arthur Geraghty, Peng Kuan Chan, Lan Hu.
  • Audit Committee chaired by Peng Kuan Chan; members include Richard Arthur Moscicki, James Arthur Geraghty.
  • Remuneration Committee chaired by Richard Arthur Moscicki; members include Wei Zhao, Lan Hu.
  • Nomination and Corporate Governance Committee chaired by James Qun Xue; members include Tingwei Wang, James Arthur Geraghty, Peng Kuan Chan, Lan Hu.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canbridge Pharmaceuticals Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260806-12274272), on August 05, 2026, and is solely responsible for the information contained therein.